United Kingdom

Our company, Ranbaxy (UK), plays a significant role in our European presence. We have grown our portfolio of offerings by inducting products from the Ranbaxy stable as well as being the preferred partner for other companies licensing out their products.
At a Glance
Launched Operations: 1994
No. of Molecules: 80
Leading Molecules: Esomeprazole, Tamsulosin, Simvastatin, Venlafaxine, Acyclovir, Ranitidine
Presence in Therapeutic Segments: Cardiovasculars, Central Nervous System (CNS), Gastrointestinal, Diabetes, Pain management, Non-steroidal Anti-inflammatory Drugs (NSAID)
Important Product Information
Contact Detail
V. Rama Seshadri
Country Manager-NEA & UK
RANBAXY HOLDINGS (U.K.) LTD
Building 4, Chiswick Park,
566 Chiswick High Road,
London, W4 5YE,
UK
![]() |
+442 -087 425 250 |
![]() |
+442 -087 425 290 |
![]() |
customerservice.uk@ranbaxy.com |
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement.
The products listed in this page are meant only of the specific country(ies) mentioned in this page and not for any other market or country.
Ranbaxy Global ▼


